NCT07247383 2025-11-25Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT LymphomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Active not recruiting39 enrolled